Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human histone H1.3 and recombinant human N-bis-met-histone H1.3

EU orphan designation number: EU/3/07/516   
Active ingredient: Recombinant human histone H1.3 and recombinant human N-bis-met-histone H1.3
Indication: Treatment of acute myeloid leukaemia
Sponsor: Xenetic Biosciences Plc
London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/12/2007 Centralised Orphan - Designation EMEA/OD/087/07 (2007)6805 of 20/12/2007
15/10/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/087/07/T/01 (2012)7219 of 10/10/2012